Novartis is taming nuclear power and putting it to use to treat advanced cancer.

The most lethal strain could be eliminated by 2030, but major hurdles remain.

Novartis team shares results of a massive oncology experiment with the world to accelerate drug discovery.

Survey results highlight the need for concerted action to guard against a fresh upsurge in the disease.

Novartis data scientists are using super-resolution microscopy to see neurodegeneration the moment it starts.

A conversation with Novartis Chief Digital Officer Bertrand Bodson

Caring for a baby with retinopathy of prematurity (ROP) has never been easy. But mother and social visionary Silke Mader has made it her life’s work to ensure that parents dealing with ROP and other complications today get more support than she did.

By growing human tumors in mice, NIBR develops a unique system that seeks to mimic clinical trials of cancer drugs

Novartis researchers have discovered a compound that is showing promise against three parasites that cause three neglected diseases.